InBody Co.,Ltd (KOSDAQ:041830)
South Korea · Delayed Price · Currency is KRW 28,000
+400 (1.45%)
Nov 20, 2025, 3:30 PM KST
InBody Co.,Ltd Market Cap
InBody Co.,Ltd has a market cap or net worth of 336.51 billion as of November 20, 2025. Its market cap has increased by 9.92% in one year.
Market Cap
336.51B
Enterprise Value
251.70B
Revenue
217.55B
Ranking
n/a
PE Ratio
11.45
Stock Price
28,000.00
Market Cap Chart
Since November 3, 2004, InBody Co.,Ltd's market cap has increased from 10.60B to 336.51B, an increase of 3,073.99%. That is a compound annual growth rate of 17.84%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 19, 2025 | 336.51B | 13.11% |
| Dec 30, 2024 | 297.52B | -9.91% |
| Dec 28, 2023 | 330.23B | 25.50% |
| Dec 29, 2022 | 263.14B | -12.74% |
| Dec 30, 2021 | 301.57B | 33.43% |
| Dec 30, 2020 | 226.02B | -28.16% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 86.90T |
| Celltrion | 40.49T |
| ALTEOGEN | 29.90T |
| SK Biopharmaceuticals | 9.93T |
| ABL Bio | 9.18T |
| Yuhan | 8.97T |
| Peptron | 7.28T |
| HLB Co., Ltd. | 6.53T |